Literature DB >> 14748065

Measurement of antirotavirus IgM/IgA/IgG responses in the serum samples of Indian children following rotavirus diarrhoea and their mothers.

Pratibha G Ray1, Shobhana D Kelkar.   

Abstract

Rotavirus specific, serum IgM/IgA/IgG levels among hospitalized children and their respective mothers were determined. Children were grouped as having rotavirus diarrhoea (RVD) and non-rotavirus diarrhoea (NRVD) on the basis of fecal excretion measured by ELISA and RT-PCR. Although IgM seropositivity was observed among children of both the groups, it was significantly higher in the acute as well as convalescent phase serum samples (P < 0.05 for both) of RVD group. Five out of ten acute sera from the NRVD group were positive for IgM and seven showed IgA/IgG seroconversion indicating rotavirus infection among these children in the past. It was noted that, three out of 24 mothers' sera from RVD group, showed presence of IgM in the serum collected during convalescence of their children. The observation suggests, subclinical rotavirus infection among mothers probably contacted from their children. This is supported by the seroconversion for IgA/IgG among these three mothers. Such a phenomenon was not noticed among the mothers from NRVD group. In general, IgA positivity did not vary significantly among the children from both the groups. IgA seropositivity was significantly higher (P < 0.001) from children of RVD group as compared to healthy group of children following rotavirus infection. From RVD group, all the child patients and 12 mothers out of 24 (50%) showed IgA/IgG seroconversion. None of the mothers from NRVD group showed seroconversion. Serum samples of healthy children and adults, showed IgM positivity at equal level (10%), but a significant difference (P < 0.01) was observed in IgA positivity. In conclusion, subclinical transmission of rotavirus infection from children to their mothers may occur. Seroconversion alone cannot be considered as a marker of rotavirus diarrhoea in children. Moreover, about 40-50% of subjects lacked rotavirus specific IgA at protective levels, making them susceptible to rotavirus infection. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14748065     DOI: 10.1002/jmv.20020

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  6 in total

1.  Serum antibody responses in children with rotavirus diarrhea can serve as proxy for protection.

Authors:  J Xu; P Dennehy; H Keyserling; L E Westerman; Y Wang; R C Holman; J R Gentsch; R I Glass; B Jiang
Journal:  Clin Diagn Lab Immunol       Date:  2005-02

2.  Resistance to rotavirus infection in adult volunteers challenged with a virulent G1P1A[8] virus correlated with serum immunoglobulin G antibodies to homotypic viral proteins 7 and 4.

Authors:  Lijuan Yuan; Shinjiro Honma; Inyoung Kim; Albert Z Kapikian; Yasutaka Hoshino
Journal:  J Infect Dis       Date:  2009-11-01       Impact factor: 5.226

3.  Prevalence of neutralizing antibodies against different rotavirus serotypes in children with severe rotavirus-induced diarrhea and their mothers.

Authors:  Pratibha G Ray; Shobhana D Kelkar
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

4.  Association of Maternal Immunity with Rotavirus Vaccine Immunogenicity in Zambian Infants.

Authors:  Roma Chilengi; Michelo Simuyandi; Lauren Beach; Katayi Mwila; Sylvia Becker-Dreps; Devy M Emperador; Daniel E Velasquez; Samuel Bosomprah; Baoming Jiang
Journal:  PLoS One       Date:  2016-03-14       Impact factor: 3.240

5.  Characterization of group A rotavirus infections in adolescents and adults from Pune, India: 1993-1996 and 2004-2007.

Authors:  Vaishali S Tatte; Jon R Gentsch; Shobha D Chitambar
Journal:  J Med Virol       Date:  2010-03       Impact factor: 2.327

6.  Association of serum antibodies with protection against rotavirus infection and disease in South Indian children.

Authors:  Prasanna Premkumar; Ben Lopman; Sasirekha Ramani; Anu Paul; Beryl Gladstone; Jayaprakash Muliyil; Indrani Mukhopadhya; Umesh Parashar; Gagandeep Kang
Journal:  Vaccine       Date:  2014-08-11       Impact factor: 3.641

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.